drugset / Trial / NCT03709992
Trospium Chloride vs Tamsulosin in Treatment of Ureteral Stent Related Symptoms:
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will be conducted to compare the efficacy and safety of Trospium chloride versus Tamsulosin for treatment of ureteral stent related symptoms.
Timeline
- Start
- 2020-12-18
- Primary completion
- 2024-08-01
- Completion
- 2024-11-01
Outcome
Outcome not reported
Stopped: “Because of COVID-19 Crisis”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tamsulosin | Other / unclassified | 0.4 mg | — |
| Comparator | Trospium | Small molecule | 30 mg | — |